Coronavirus

The Pharmacy Times® Coronavirus resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

FDA Approves Remdesivir for Certain Patients With COVID-19
What can we help you find?
[[thumbnail_alt_text]]
Liam Townsend, MD, and his co-authors looked at a number of measures of recovery for 153 patients who were followed in an outpatient clinic a median of 75 days after their COVID-19 diagnoses.
[[thumbnail_alt_text]]
Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on whether any unforeseen problems have arisen during the first wave of COVID-19 vaccinations at long-term care facilities.
[[thumbnail_alt_text]]
Approximately one-third of children with COVID-19 are asymptomatic, according to a study conducted by researchers at the University of Alberta.
[[thumbnail_alt_text]]
As patients with HIV are living longer, they are also being diagnosed with chronic conditions that have become increasingly common in recent decades, putting them at higher risk of COVID-19 hospitalization and death.
 
[[thumbnail_alt_text]]
Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on the first wave of COVID-19 vaccine administration at long-term care facilities across the country.
[[thumbnail_alt_text]]
Study finds the COVID-19 pandemic has drastically improved the quality and convenience of virtual cancer care. 
 
[[thumbnail_alt_text]]
There is particular interest in monoclonal antibody agents to determine whether their immune suppressive effects can reduce the immediate and long-term impact of COVID-19.
[[thumbnail_alt_text]]
COVID-19 has been found in the brain post-mortem. 
 
[[thumbnail_alt_text]]
Moderna, Inc has also announced temporary authorization of its COVID-19 vaccine in Switzerland.
 
[[thumbnail_alt_text]]
The study authors said their main hypothesis for the higher prevalence of olfactory dysfunction in mild COVID-19 cases was based on differences in the immune response to the infection.
 
[[thumbnail_alt_text]]
With approximately 328 million people currently living in the United States, it will take an army of health care professionals to vaccinate the country against COVID-19.
[[thumbnail_alt_text]]
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.